DNLI
Price
$14.37
Change
-$0.06 (-0.42%)
Updated
May 9 closing price
Capitalization
2.09B
81 days until earnings call
SWTX
Price
$46.26
Change
+$0.06 (+0.13%)
Updated
May 9 closing price
Capitalization
3.47B
One day until earnings call
Ad is loading...

DNLI vs SWTX

Header iconDNLI vs SWTX Comparison
Open Charts DNLI vs SWTXBanner chart's image
Denali Therapeutics
Price$14.37
Change-$0.06 (-0.42%)
Volume$1.37M
Capitalization2.09B
SpringWorks Therapeutics
Price$46.26
Change+$0.06 (+0.13%)
Volume$3.76M
Capitalization3.47B
DNLI vs SWTX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. SWTX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and SWTX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (DNLI: $14.37 vs. SWTX: $46.26)
Brand notoriety: DNLI and SWTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 94% vs. SWTX: 75%
Market capitalization -- DNLI: $2.09B vs. SWTX: $3.47B
DNLI [@Biotechnology] is valued at $2.09B. SWTX’s [@Biotechnology] market capitalization is $3.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileSWTX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • SWTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNLI and SWTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while SWTX’s TA Score has 6 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • SWTX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SWTX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -12.59% price change this week, while SWTX (@Biotechnology) price change was +0.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

SWTX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SWTX($3.47B) has a higher market cap than DNLI($2.09B). SWTX YTD gains are higher at: 28.038 vs. DNLI (-29.490). SWTX has higher annual earnings (EBITDA): -274.66M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. SWTX (308M). SWTX has less debt than DNLI: SWTX (7.91M) vs DNLI (48.7M). SWTX has higher revenues than DNLI: SWTX (192M) vs DNLI (0).
DNLISWTXDNLI / SWTX
Capitalization2.09B3.47B60%
EBITDA-492.89M-274.66M179%
Gain YTD-29.49028.038-105%
P/E RatioN/AN/A-
Revenue0192M-
Total Cash832M308M270%
Total Debt48.7M7.91M616%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLISWTX
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRXUX14.540.07
+0.48%
MFS Blended Research Intl Eq R4
LMISX23.21-0.04
-0.17%
Franklin U.S. Large Cap Equity IS
RTSGX5.77-0.01
-0.17%
Transamerica Small Cap Growth R6
VDIGX35.03-0.07
-0.20%
Vanguard Dividend Growth Inv
SGRAX23.16-0.07
-0.30%
Allspring Growth A

SWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SWTX has been loosely correlated with ATAI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SWTX jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWTX
1D Price
Change %
SWTX100%
+0.13%
ATAI - SWTX
38%
Loosely correlated
-0.71%
IMNM - SWTX
37%
Loosely correlated
-3.24%
VCYT - SWTX
37%
Loosely correlated
-4.81%
TRDA - SWTX
37%
Loosely correlated
-2.78%
BHVN - SWTX
36%
Loosely correlated
-0.05%
More